Literature DB >> 3187532

A larger spectrum of severe HIV-1--related disease in intravenous drug users in New York City.

R L Stoneburner1, D C Des Jarlais, D Benezra, L Gorelkin, J L Sotheran, S R Friedman, S Schultz, M Marmor, D Mildvan, R Maslansky.   

Abstract

Increasing mortality in intravenous (IV) drug users not reported to surveillance as acquired immunodeficiency syndrome (AIDS) has occurred in New York City coincident with the AIDS epidemic. From 1981 to 1986, narcotics-related deaths increased on average 32% per year from 492 in 1981 to 1996 in 1986. This increase included deaths from AIDS increasing from 0 to 905 and deaths from other causes, many of which were infectious diseases, increasing from 492 to 1091. Investigations of these deaths suggest a causal association with human immunodeficiency virus (HIV) infection. These deaths may represent a spectrum of HIV-related disease that has not been identified through AIDS surveillance and has resulted in a large underestimation of the impact of AIDS on IV drug users and blacks and Hispanics.

Entities:  

Mesh:

Year:  1988        PMID: 3187532     DOI: 10.1126/science.3187532

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  30 in total

Review 1.  Microbial infections, immunomodulation, and drugs of abuse.

Authors:  Herman Friedman; Catherine Newton; Thomas W Klein
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

2.  Investigation of pulmonary disease in HIV infection.

Authors:  P J Flegg; L J Willocks; R P Brettle; A G Bird
Journal:  Thorax       Date:  1990-10       Impact factor: 9.139

3.  AIDS and racism in America.

Authors:  J Hutchinson
Journal:  J Natl Med Assoc       Date:  1992-02       Impact factor: 1.798

Review 4.  Harm reduction theory: users' culture, micro-social indigenous harm reduction, and the self-organization and outside-organizing of users' groups.

Authors:  Samuel R Friedman; Wouter de Jong; Diana Rossi; Graciela Touzé; Russell Rockwell; Don C Des Jarlais; Richard Elovich
Journal:  Int J Drug Policy       Date:  2006-12-28

5.  Injection drug use, mortality, and the AIDS epidemic.

Authors:  P A Selwyn
Journal:  Am J Public Health       Date:  1991-10       Impact factor: 9.308

6.  Bleach programs for preventing AIDS among i.v. drug users: modeling the impact of HIV prevalence.

Authors:  J E Siegel; M C Weinstein; H V Fineberg
Journal:  Am J Public Health       Date:  1991-10       Impact factor: 9.308

7.  Impact of the AIDS epidemic on morbidity and mortality among intravenous drug users in a New York City methadone maintenance program.

Authors:  P A Selwyn; D Hartel; W Wasserman; E Drucker
Journal:  Am J Public Health       Date:  1989-10       Impact factor: 9.308

8.  HIV-1 incidence and HIV-1 associated mortality in a cohort of urban factory workers in Tanzania.

Authors:  M W Borgdorff; L R Barongo; A H Klokke; J N Newell; K P Senkoro; J P Velema; R M Gabone
Journal:  Genitourin Med       Date:  1995-08

9.  Implications of the revised surveillance definition: AIDS among New York City drug users.

Authors:  D C Des Jarlais; J Wenston; S R Friedman; J L Sotheran; R Maslansky; M Marmor; S Yancovitz; S Beatrice
Journal:  Am J Public Health       Date:  1992-11       Impact factor: 9.308

10.  Public health triangulation: approach and application to synthesizing data to understand national and local HIV epidemics.

Authors:  George W Rutherford; William McFarland; Hilary Spindler; Karen White; Sadhna V Patel; John Aberle-Grasse; Keith Sabin; Nathan Smith; Stephanie Taché; Jesus M Calleja-Garcia; Rand L Stoneburner
Journal:  BMC Public Health       Date:  2010-07-29       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.